Robin M. Hallett
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumors.
Journal: ESMO open
Published: February 25, 2022
Vitamin D Receptor Activation Attenuates Hippo Pathway Effectors and Cell Survival in Metastatic Neuroblastoma.
Journal: Molecular cancer research : MCR
Published: June 08, 2021
Therapeutic Targeting of LIF Overcomes Macrophage-mediated Immunosuppression of the Local Tumor Microenvironment.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 24, 2021
Monoamine oxidase-A activity is required for clonal tumorsphere formation by human breast tumor cells.
Journal: Cellular & molecular biology letters
Published: July 11, 2019
Wnt activation as a therapeutic strategy in medulloblastoma.
Journal: Nature communications
Published: June 07, 2019
BMI1 is a therapeutic target in recurrent medulloblastoma.
Journal: Oncogene
Published: February 20, 2018
Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenografts.
Journal: Oncotarget
Published: November 25, 2016
The identification of human pituitary adenoma-initiating cells.
Journal: Acta neuropathologica communications
Published: November 16, 2016
A Metastatic Mouse Model Identifies Genes That Regulate Neuroblastoma Metastasis.
Journal: Cancer research
Published: June 02, 2016
Last Updated: 09/26/2026